ACM
Ayrshire Capital Management Portfolio holdings
AUM
$208M
This Quarter Return
+12.13%
1 Year Return
+18.61%
3 Year Return
+76.93%
5 Year Return
+120.41%
10 Year Return
–
AUM
$173M
AUM Growth
+$173M
(+12%)
Cap. Flow
+$1.78M
Cap. Flow
% of AUM
1.03%
Top 10 Holdings %
Top 10 Hldgs %
39.73%
Holding
51
New
4
Increased
32
Reduced
9
Closed
3
Top Buys
| 1 |
Eaton
ETN
|
$3.14M |
| 2 |
Procter & Gamble
PG
|
$836K |
| 3 |
Veralto
VLTO
|
$708K |
| 4 |
Wells Fargo
WFC
|
$370K |
| 5 |
Vanguard S&P 500 ETF
VOO
|
$366K |
Top Sells
| 1 |
Dover
DOV
|
$2.91M |
| 2 |
Moderna
MRNA
|
$2.05M |
| 3 |
Colgate-Palmolive
CL
|
$400K |
| 4 |
Golub Capital BDC
GBDC
|
$215K |
| 5 |
American Tower
AMT
|
$116K |
Sector Composition
| 1 | Technology | 31.24% |
| 2 | Healthcare | 18.08% |
| 3 | Financials | 16.29% |
| 4 | Consumer Staples | 12.84% |
| 5 | Consumer Discretionary | 11.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
AB InBev
BUD
$122B
| $3.81M | 2.2% |
58,912
+2,236
| +4% | +$144K |
|
27
Eli Lilly
LLY
$657B
| $3.62M | 2.09% |
6,205
+269
| +5% | +$157K |
|
|
28
Eaton
ETN
$136B
| $3.14M | 1.81% |
+13,040
| New | +$3.14M |
|
29
Nike
NKE
$114B
| $2.83M | 1.63% |
26,087
+420
| +2% | +$45.6K |
|
|
30
Colgate-Palmolive
CL
$67.9B
| $2.54M | 1.47% |
31,913
-5,020
| -14% | -$400K |
|
31
SPDR S&P 500 ETF Trust
SPY
$658B
| $1.47M | 0.85% |
3,087
+69
| +2% | +$32.8K |
|
32
Qualcomm
QCOM
$173B
| $1.32M | 0.76% |
9,094
-85
| -0.9% | -$12.3K |
|
33
Salesforce
CRM
$245B
| $1.25M | 0.72% |
4,748
+9
| +0.2% | +$2.37K |
|
34
Ares Capital
ARCC
$15.8B
| $1.18M | 0.68% |
58,943
+1,796
| +3% | +$36K |
|
|
35
American Tower
AMT
$95.5B
| $1.04M | 0.6% |
4,821
-537
| -10% | -$116K |
|
36
Amgen
AMGN
$155B
| $1.02M | 0.59% |
3,546
+62
| +2% | +$17.9K |
|
|
37
Veralto
VLTO
$26.4B
| $708K | 0.41% |
+8,608
| New | +$708K |
|
38
ConocoPhillips
COP
$124B
| $648K | 0.37% |
5,581
+59
| +1% | +$6.85K |
|
39
iShares Core Dividend Growth ETF
DGRO
$33.7B
| $529K | 0.31% |
9,837
+199
| +2% | +$10.7K |
|
40
S&P Global
SPGI
$167B
| $441K | 0.25% |
1,000
-4
| -0.4% | -$1.76K |
|
41
Gilead Sciences
GILD
$140B
| $437K | 0.25% |
5,400
| – | – |
|
42
SPDR S&P MidCap 400 ETF Trust
MDY
$23.7B
| $411K | 0.24% |
810
+1
| +0.1% | +$507 |
|
|
43
Wells Fargo
WFC
$263B
| $370K | 0.21% |
+7,510
| New | +$370K |
|
|
44
Vanguard S&P 500 ETF
VOO
$726B
| $366K | 0.21% |
+837
| New | +$366K |
|
45
Berkshire Hathaway Class B
BRK.B
$1.09T
| $323K | 0.19% |
905
+20
| +2% | +$7.13K |
|
46
NVIDIA
NVDA
$4.24T
| $313K | 0.18% |
633
+84
| +15% | +$41.6K |
|
|
SBT
47
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $75.6K | 0.04% |
13,102
| – | – |
|
|
48
Dover
DOV
$24.5B
| – | – |
-20,873
| Closed | -$2.91M |
|
|
49
Golub Capital BDC
GBDC
$3.97B
| – | – |
-14,634
| Closed | -$215K |
|
|
50
Moderna
MRNA
$9.37B
| – | – |
-19,855
| Closed | -$2.05M |
|